Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2019 Filed Feb 21, 2019 22:49 UTC |
Ladd DelanoEVP, Counsel & Secretary
|
SaleCommon Stock | 6,875 | $78.00 | $536,250.00 |
DisclosureSEC source: 0001179110-19-002264 · edgar.xml · nonDerivative · entry 2 Ladd Delano · CIK 0001683056 · EVP, Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,465 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018. Read SEC document |
| February 20, 2019 Filed Feb 21, 2019 22:49 UTC |
Ladd DelanoEVP, Counsel & Secretary
|
Exercise / conversionCommon Stock | 6,875 | $30.57 | $210,168.75 |
DisclosureSEC source: 0001179110-19-002264 · edgar.xml · nonDerivative · entry 1 Ladd Delano · CIK 0001683056 · EVP, Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:03 UTC |
SELANDER ROBERT WDirector
|
GrantCommon Stock | 2,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001380 · edgar.xml · nonDerivative · entry 2 SELANDER ROBERT W · CIK 0001160228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,669 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 569 shares on February 1, 2019. The remaining restricted stock units vest as to 569 shares on May 1, 2019, and 570 shares on each of August 1, 2019 and November 1, 2019. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:03 UTC |
SELANDER ROBERT WDirector
|
GrantCommon Stock | 2,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001380 · edgar.xml · nonDerivative · entry 1 SELANDER ROBERT W · CIK 0001160228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,391 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,296 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2020. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:59 UTC |
DILLON ADRIAN TDirector
|
GrantStock Options (right to buy) · Derivative | 3,626 | $0.00 Strike: $63.64 | $0.00 |
DisclosureSEC source: 0001179110-19-001366 · edgar.xml · derivative · entry 6 DILLON ADRIAN T · CIK 0001163402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,626 Underlying: Common Stock · 3,626 shares Expires 2029-02-01 F5 · derivative.exercise_date: The option becomes exercisable as to 1,813 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will become exercisable on January 31, 2020. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:59 UTC |
DILLON ADRIAN TDirector
|
GrantCommon Stock | 1,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001366 · edgar.xml · nonDerivative · entry 2 DILLON ADRIAN T · CIK 0001163402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,635 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 304 shares on February 1, 2019. The remaining restricted stock units vest as to 304 shares on May 1, 2019, and 305 shares on each of August 1, 2019, and November 1, 2019. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:59 UTC |
DILLON ADRIAN TDirector
|
GrantCommon Stock | 1,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001366 · edgar.xml · nonDerivative · entry 1 DILLON ADRIAN T · CIK 0001163402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,417 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 648 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2020. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:01 UTC |
Wellborn Gayle FurgursonDirector
|
GrantCommon Stock | 2,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001373 · edgar.xml · nonDerivative · entry 1 Wellborn Gayle Furgurson · CIK 0001712960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,667 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,296 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2020. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:11 UTC |
Corvino FrankDirector
|
GrantCommon Stock | 2,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001390 · edgar.xml · nonDerivative · entry 1 Corvino Frank · CIK 0001614878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,644 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,296 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2020. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:09 UTC |
Dilsaver Evelyn SDirector
|
GrantCommon Stock | 2,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001389 · edgar.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,786 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,296 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2020. Vested shares will be delivered to the reporting person on February 1, 2023. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:08 UTC |
McCowan Debra CharlotteDirector
|
GrantCommon Stock | 2,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001388 · edgar.xml · nonDerivative · entry 1 McCowan Debra Charlotte · CIK 0001735093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,602 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,296 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2020. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:06 UTC |
Medici FrankDirector
|
GrantCommon Stock | 943 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001387 · edgar.xml · nonDerivative · entry 2 Medici Frank · CIK 0001614857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,281 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 235 shares on February 1, 2019. The remaining restricted stock units vest as to 236 shares on each of May 1, 2019, August 1, 2019, and November 1, 2019. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:06 UTC |
Medici FrankDirector
|
GrantCommon Stock | 2,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001387 · edgar.xml · nonDerivative · entry 1 Medici Frank · CIK 0001614857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,338 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,296 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2020. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:04 UTC |
Sacks IanDirector
|
GrantCommon Stock | 1,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001385 · edgar.xml · nonDerivative · entry 2 Sacks Ian · CIK 0001614866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,796 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 284 shares on February 1, 2019. The remaining restricted stock units vest as to 285 shares on each of May 1, 2019, August 1, 2019, and November 1, 2019. Vested shares will be delivered to the reporting person on February 1, 2021. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:04 UTC |
Sacks IanDirector
|
GrantCommon Stock | 2,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001385 · edgar.xml · nonDerivative · entry 1 Sacks Ian · CIK 0001614866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,657 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,296 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2020. Vested shares will be delivered to the reporting person on February 1, 2021. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 12:03 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 1,200 | $61.74 | $74,089.68 |
DisclosureSEC source: 0001179110-19-000890 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.27 to $62.14, inclusive. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 12:03 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 2,800 | $60.41 | $169,161.44 |
DisclosureSEC source: 0001179110-19-000890 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.12 to $61.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) of this Form 4. Read SEC document |
| December 20, 2018 Filed Dec 26, 2018 13:15 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 4,000 | $60.28 | $241,111.20 |
DisclosureSEC source: 0001179110-18-014250 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.85 to $60.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 of this Form 4. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 19:17 UTC |
Trittschuh Larry LEVP Chief Security Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,678 | $0.00 Strike: $59.63 | $0.00 |
DisclosureSEC source: 0001179110-18-014161 · edgar.xml · derivative · entry 2 Trittschuh Larry L · CIK 0001761050 · EVP Chief Security Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,678 Underlying: Common Stock · 25,678 shares Expires 2028-12-17 F2 · derivative.exercise_date: The option becomes exercisable as to 6,420 shares in equal annual installments on December 17, 2019 and 2020. The remaining shares become exercisable in equal annual installments of 6,419 on December 17, 2021 and 2022. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 19:17 UTC |
Trittschuh Larry LEVP Chief Security Officer
|
GrantCommon Stock | 10,481 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-014161 · edgar.xml · nonDerivative · entry 1 Trittschuh Larry L · CIK 0001761050 · EVP Chief Security Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,481 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 2,621 shares on December 17, 2019. The remaining shares vest in equal amounts of 2,620 annually on each of December 17, 2020, 2021 and 2022. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:29 UTC |
Kessler JonDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,410 | $0.00 Strike: $41.28 | $0.00 |
DisclosureSEC source: 0001179110-18-014071 · edgar.xml · derivative · entry 2 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,229 Underlying: Common Stock · 17,410 shares Expires 2027-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable as to 17,410 shares on March 27, 2018. The remaining options will become exercisable in two annual installments of 17,410 shares on March 27, 2019 and 2020. The option becomes exercisable as to the remaining 17, 409 shares on March 27, 2021. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:29 UTC |
Kessler JonDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,410 | $41.28 | $718,684.80 |
DisclosureSEC source: 0001179110-18-014071 · edgar.xml · nonDerivative · entry 1 Kessler Jon · CIK 0001615062 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 01:05 UTC |
Corvino FrankDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,068 | $0.00 Strike: $21.27 | $0.00 |
DisclosureSEC source: 0001179110-18-013791 · edgar.xml · derivative · entry 4 Corvino Frank · CIK 0001614878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,932 Underlying: Common Stock · 2,068 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 01:05 UTC |
Corvino FrankDirector
|
SaleCommon Stock | 2,068 | $70.81 | $146,426.60 |
DisclosureSEC source: 0001179110-18-013791 · edgar.xml · nonDerivative · entry 3 Corvino Frank · CIK 0001614878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,051 Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 01:05 UTC |
Corvino FrankDirector
|
Exercise / conversionCommon Stock | 2,068 | $21.27 | $43,986.36 |
DisclosureSEC source: 0001179110-18-013791 · edgar.xml · nonDerivative · entry 2 Corvino Frank · CIK 0001614878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 13, 2018 01:05 UTC |
Corvino FrankDirector
|
SaleCommon Stock | 1,778 | $67.78 | $120,508.40 |
DisclosureSEC source: 0001179110-18-013791 · edgar.xml · nonDerivative · entry 1 Corvino Frank · CIK 0001614878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,051 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.74 to $67.86 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:57 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 195 | $78.42 | $15,292.50 |
DisclosureSEC source: 0001179110-18-013114 · edgar.xml · nonDerivative · entry 5 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.35 to $78.50, inclusive. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:57 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 2,105 | $77.84 | $163,857.41 |
DisclosureSEC source: 0001179110-18-013114 · edgar.xml · nonDerivative · entry 4 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,195 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.33 to $78.10, inclusive. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:57 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 500 | $76.84 | $38,421.00 |
DisclosureSEC source: 0001179110-18-013114 · edgar.xml · nonDerivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.26 to $77.18, inclusive. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:57 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 700 | $75.48 | $52,839.01 |
DisclosureSEC source: 0001179110-18-013114 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,800 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.06 to $75.95, inclusive. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:57 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 500 | $74.44 | $37,219.00 |
DisclosureSEC source: 0001179110-18-013114 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.01 to $74.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2, 3, 4, 5) and (6) to this Form 4. Read SEC document |
| October 22, 2018 Filed Oct 23, 2018 17:52 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 2,500 | $87.28 | $218,203.50 |
DisclosureSEC source: 0001179110-18-012312 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.09 to $87.46, inclusive. Read SEC document |
| October 22, 2018 Filed Oct 23, 2018 17:52 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 1,500 | $86.56 | $129,839.55 |
DisclosureSEC source: 0001179110-18-012312 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.96 to $86.87, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| September 20, 2018 Filed Sep 21, 2018 17:10 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 2,100 | $93.34 | $196,004.55 |
DisclosureSEC source: 0001179110-18-011614 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.95 to $93.60, inclusive. Read SEC document |
| September 20, 2018 Filed Sep 21, 2018 17:10 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 1,900 | $92.48 | $175,708.01 |
DisclosureSEC source: 0001179110-18-011614 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.92 to $92.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 16:29 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 1,200 | $86.92 | $104,298.00 |
DisclosureSEC source: 0001179110-18-010775 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.65 to $87.54, inclusive. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 16:29 UTC |
MOTT DARCY GExecutive VP and CFO
|
SaleCommon Stock | 2,800 | $86.14 | $241,200.96 |
DisclosureSEC source: 0001179110-18-010775 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.59 to $86.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 18:28 UTC |
Bloomberg EdwardChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,667 | $0.00 Strike: $82.39 | $0.00 |
DisclosureSEC source: 0001179110-18-010599 · edgar.xml · derivative · entry 2 Bloomberg Edward · CIK 0001747302 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,667 Underlying: Common Stock · 25,667 shares Expires 2028-08-13 F2 · derivative.exercise_date: The option becomes exercisable as to 6,417 shares in annual installments on each of August 13, 2019, 2020, and 2021. The remaining 6,416 shares become exercisable on August 13, 2022. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 18:28 UTC |
Bloomberg EdwardChief Operating Officer
|
GrantCommon Stock | 10,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010599 · edgar.xml · nonDerivative · entry 1 Bloomberg Edward · CIK 0001747302 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,620 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 2,655 shares annually on each of August 13, 2019, 2020, 2021 and 2022. Read SEC document |
| July 13, 2018 Filed Jul 16, 2018 21:21 UTC |
Medici FrankDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,904 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009706 · edgar.xml · derivative · entry 3 Medici Frank · CIK 0001614857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,904 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| July 13, 2018 Filed Jul 16, 2018 21:21 UTC |
Medici FrankDirector
|
SaleCommon Stock | 6,904 | $80.40 | $555,049.15 |
DisclosureSEC source: 0001179110-18-009706 · edgar.xml · nonDerivative · entry 2 Medici Frank · CIK 0001614857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,745 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.35 to $80.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| July 13, 2018 Filed Jul 16, 2018 21:21 UTC |
Medici FrankDirector
|
Exercise / conversionCommon Stock | 6,904 | $14.00 | $96,656.00 |
DisclosureSEC source: 0001179110-18-009706 · edgar.xml · nonDerivative · entry 1 Medici Frank · CIK 0001614857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 21:41 UTC |
Medici FrankDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,596 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009650 · edgar.xml · derivative · entry 3 Medici Frank · CIK 0001614857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,904 Underlying: Common Stock · 15,596 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 21:41 UTC |
Medici FrankDirector
|
SaleCommon Stock | 15,596 | $80.15 | $1,249,980.41 |
DisclosureSEC source: 0001179110-18-009650 · edgar.xml · nonDerivative · entry 2 Medici Frank · CIK 0001614857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,745 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.05 to $80.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 21:41 UTC |
Medici FrankDirector
|
Exercise / conversionCommon Stock | 15,596 | $14.00 | $218,344.00 |
DisclosureSEC source: 0001179110-18-009650 · edgar.xml · nonDerivative · entry 1 Medici Frank · CIK 0001614857 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 22:56 UTC |
Dilsaver Evelyn SDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $25.39 | $0.00 |
DisclosureSEC source: 0001179110-18-009540 · edgar.xml · derivative · entry 4 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 22:56 UTC |
Dilsaver Evelyn SDirector
|
SaleCommon Stock | 15,000 | $77.46 | $1,161,936.00 |
DisclosureSEC source: 0001179110-18-009540 · edgar.xml · nonDerivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,193 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.35 to $77.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 22:56 UTC |
Dilsaver Evelyn SDirector
|
Exercise / conversionCommon Stock | 15,000 | $25.39 | $380,850.00 |
DisclosureSEC source: 0001179110-18-009540 · edgar.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 22:33 UTC |
Otten William RobertExecutive VP of Sales
|
Tax withholdingCommon Stock | 764 | $81.36 | $62,159.04 |
DisclosureSEC source: 0001179110-18-009018 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,835 Read SEC document |
| June 12, 2018 Filed Jun 18, 2018 22:35 UTC |
Neeleman StephenDirector · Founder and Vice Chairman
|
GiftCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008724 · edgar.xml · nonDerivative · entry 2 Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 566,285 F1 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.